Author

I. W. Vock

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1

Frequent Co-Authors

A. J. L. Huldin· 1 shared A. Mapp· 1 shared J. A. Schofield· 1 shared J. T. Zimmer· 1 shared L. Kiefer· 1 shared M. D. Simon· 1 shared M. H. Moon· 1 shared M. J. Beyersdorf· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiochemistry

A. J. L. Huldin

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BiochemistrybioRxivPreprintMay 24, 2023

Improving the study of RNA dynamics through advances in RNA-seq with metabolic labeling and nucleotide-recoding chemistry

J. T. Zimmer, I. W. Vock, J. A. Schofield…·M. D. Simon

This paper identifies and mitigates dropout in RNA metabolic labeling and NR-seq experiments through optimized protocols and improved alignment pipelines.

DOI 10.1101/2023.05.24.542133

bulk RNA-seqexperimental assay

𝕏 PostBluesky

BiochemistrybioRxivApr 28, 2021

A Dual-Site Inhibitor of CBP/p300 KIX is a Selective and Effective Modulator of Myb

S. T. Joy, M. J. Henley, S. N. De Salle…·A. Mapp

This paper develops a dual-site inhibitor, MybLL-tide, that selectively targets the CBP/p300 KIX domain, inhibiting Myb-dependent gene expression in AML cells.

DOI 10.1021/jacs.1c04432

humanexperimental assay

𝕏 PostBluesky